skip to main content

Prof. Samuel Wagner, PhD

Contact

Institute for Medical Microbiology and Hygiene

Elfriede-Aulhorn-Straße 6
72076 Tübingen, Germany

samuel.wagner@med.uni-tuebingen.de

Tel.: +49 7071 29-84238

 

 

Research Interest

Samuel Wagner's research interests include the development of anti-infectives that block virulence mechanisms. The focus is on the analysis of the structure and function of the virulence-associated secretion systems of pathogenic bacteria, in particular the type III secretion system (T3SS) of Salmonella Typhimurium and the type IV secretion system of Legionella pneumophila. These secretion systems enable the potential pathogenic bacteria to infect a host cell.

Website Research Group Wagner

 

 

About Samuel Wagner

Samuel Wagner studied human biology at the Philipps University of Marburg and then went to Sweden for his master's degree in biomedicine at the Karolinska Institute.There, he earned a doctorate in biochemistry in 2008, followed by a period as a postdoctoral researcher at the Yale School of Medicine before he came to the University of Tübingen in 2012 as an assistant professor of infection biology. Since 2015, Samuel Wagner has been head of the Section for Cellular and Molecular Microbiology at the Institute for Microbiology and Hygiene at the University Hospital Tübingen. In 2018, Samuel Wagner took up the professorship of Infection Biology at the University of Tübingen. Since 2019, he is Director of Graduate Studies of the Interfaculty Graduate School of Infection Biology and Microbiology (IGIM), Deputy Director of the Interfaculty Institute for Microbiology and Infection Medicine Tübingen (IMIT) and member of the CMFI Board. Since 2020, he has also been the co-coordinator of the TTU Gastrointestinal Infections of the German Center for Infection Research (DZIF) and Vice Dean of the Faculty of Medicine for the areas of digitalization and young scientists.

Samuel Wagner is a member of various expert groups and commissions, such as the Expert Group Microbial Pathogenicity (DGHM/VAAM), the Study Commission Molecular Medicine, Research Commission and Task Force Technology Transfer of the Faculty of Medicine and the Competence Team Pharmadialog Antibiotics (BMBF).

Prizes and Awards

In addition to grants from the European Molecular Biology Organization (EMBO) and the Human Frontier Science Program (HFSP), Samuel Wagner received the Sofja Kovalevskaja Award from the Alexander von Humboldt Foundation in 2012, the Capital Junge Elite 4x40 under 40 Award, and the DGHM Förderpreis.

Publications

You can find a list of publications here

Pubmed